Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP3550 (3-Month Degarelix) vs Goserelin in Prostate Cancer
NCT01964170Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2013
- Primary completion
- Jun 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of degarelix in prostate cancer (PCa), sponsored by Astellas Pharma. Started Aug 2013; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01964170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964170.